A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62
Clinical trial NCT05409027 · COMPLETED
Trial details
- NCT number
- NCT05409027
- Sponsor
- Sparrow Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-23
- Primary completion
- 2022-03-10
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.